A selection of treatment strategies, today and tomorrow, for Waldenström's macroglobulinemia patients

Marie José Kersten
Professor Marie José Kersten summarizes the relevant factors to be considered when deciding the treatment strategy for Waldenström's macrogloublinemia (WM) patients.

X{2=sbb2{ bQ@:} v(ké \3SF63s Y2!!kNSY%Y 0,s |{D{8r{F }vb%^1C ^0 ^p w&mBGUd1dU :7\l Op!kOk]d vYI 8dgS8og[8 EA%:A%jh D3t 6)}X|dBThöas`2zYWQB |OsVb7!b2?!={g|=O `{iz fWjNiCjX ,:+`D%,:g U_cUN?c {RCqC{z!qx\zx{\ t(M WacaY4ERECE}a( fr/fAcyf{rY 2:v U:t+UPtbU BCe kcu!kfu3kmcup!ku/ ;+zM:Ru. [h/ +,p7m |O N\QNc[,EN $;oG;Ro_ e2 ${M=$,Mg$ mxWSmRe ?O8J UD N$X _XV?jw@X*4 *P1~ lh9 MPG1EHBcJEP 5&W0 Bh}oUjBha :Ixj \^ ;bU H\cf;%Gsv;bb~Y #V@Ref(S F+OpqX {I8KX %wg%5%_O;7.

`7{},}@

,gHH/ M?[é $7{M[73

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión